UNSPSC 51282809: Nimorazole

This classification denotes an antiprotozoal agent with the molecular formula C9H14N4O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 469ULX0H4G, chemically known as morpholine, 4-(2-(5-nitroimidazol-1-yl)ethyl)- but generally known as nimorazole, which bears US NIH Compound Identifier 23009. European Medicines Agency schedules Nimorazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09298MIG.

UNSPSC 51282809 Nimorazole is a Commodity code that, despite its nominal scope, does not align with the state and local procurement activity currently tagged under it. The recent opportunities posted under this code reflect procurement of naloxone, medical and first aid supplies for emergency response, generic pharmaceuticals and OTC products through cooperative purchasing, and direct-to-manufacturer prescription programs—none of which concern nimorazole as a pharmaceutical product. State and local governments are using this code to solicit a much broader range of pharmaceutical and medical supply acquisitions, primarily through health departments, fire and rescue services, and cooperative purchasing alliances that source generic drugs and emergency medical consumables from manufacturers and authorized wholesalers.

Activity under the code spans multiple states and procurement vehicles. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, posted a Request for Proposal on January 20, 2026 (response due March 26, 2026) for generic multi-source pharmaceuticals and OTC products distributed across participating state and local facilities, including Oregon, with contract award effective July 1, 2026. Seminole County, Florida issued an IFB on June 30, 2026 for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries, due July 26, 2023. The City of Tampa's Purchasing Department solicited sealed bids (26P00145) for 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division, designated as sheltered market for certified Small Local Business Enterprises with a 5 percent bid discount, with an estimated contract amount of $700,000.00 and response due March 13, 2026. The Texas Health and Human Services Commission issued a Request for Information in April 2026 to explore vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program. This code shows little relevant recent activity—the tagging appears inconsistent with the code's intended scope, limiting its utility for business development targeting nimorazole sales specifically.